Abstract

Gastric cancer (GC), as a common gastrointestinal tumor, is an important cause of death from cancer all around the world. Long non-coding RNAs (lncRNAs), a novel class of transcripts, have attracted great attention of researchers. However, the mechanisms of the clinical significance of most lncRNAs in human cancer are mainly undocumented. This research desires to explore the clinical significance, biological function, and mechanism of Lnc_ASNR (apoptosis suppressing-non-coding RNA) in GC. Cell proliferation, cell cycle, cell migration, and invasion abilities were respectively determined by 3-(4,5)-dimethylthiahiazo (-z-y1)-3,5-di-phenytetrazoliumromide (MTT), flow cytometry, wound healing, and Transwell assay (Sigma-Aldrich, St. Louis, MO, United States). The association of Lnc_ASNR, miR-519e-5p, and fibroblast growth factor receptor 2 (FGFR2) was evaluated via luciferase reporter experiments. The tumor xenograft assay was conducted to confirm the results of cell experiments. High expressed Lnc_ASNR was detected in both GC cells and tissues using qRT-PCR. Downregulated Lnc_ASNR could reduce proliferation, migration, and invasion in GC cells, while upregulated Lnc_ASNR could promote the cell proliferation, migration, and invasion. Moreover, the effect of Lnc_ASNR on migration and invasion ability is closely related to epithelial-mesenchymal transition (EMT). The bioinformatics analysis, luciferase assay, and Western blot demonstrated that Lnc_ASNR inhibited miR-519e-5p expression but increased FGFR2 expression. Lnc_ASNR and FGFR2 were both targeted to miR-519e-5p, and they were negatively correlated with the expression of miR-519e-5p. All investigations indicated that Lnc_ASNR functioned as a ceRNA targeting miR-519e-5p and facilitated GC development by regulating the pathway of miR-519e-5p/FGFR2.

Highlights

  • Gastric cancer (GC) is a prevalent malignant tumor around the world with the sixth incidence rate and second mortality rate, which seriously affects human health (Bray et al, 2018)

  • Since epithelial-mesenchymal transition (EMT) is a key step that contributes to tumor metastasis, we evaluated the effect of Lnc_ASNR on EMT

  • Increasing research results verified that long non-coding RNAs (lncRNAs) are crucial in cellular progression and diseases development (Han et al, 2019; Pradas-Juni et al, 2020), especially in cancer (Papaioannou et al, 2019; Schulte et al, 2020; Silva-Fisher et al, 2020)

Read more

Summary

Introduction

Gastric cancer (GC) is a prevalent malignant tumor around the world with the sixth incidence rate and second mortality rate, which seriously affects human health (Bray et al, 2018). The advanced diagnosis and therapy of GC has achieved development in recent years. Many limitations existed that hinder the effectiveness of GC treatment. The early symptoms of most GC patients are not obvious, and diagnosis delay becomes the main obstacle of GC treatment and prognosis. The combination of gastroscopy and biopsy is the universally recognized gold standard for GC diagnosis (Virgilio et al, 2017; den Hollander et al, 2019). Its application in GC screening is still limited because it is not easy to be accepted by patients due to the invasiveness and high cost. The most commonly used tumor biomarkers in clinical are insufficient to completely replace biopsy, so it is of great significance to explore more specific and sensitive biomarkers for early diagnosis of GC to improve the clinical treatment effect

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call